A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

cyclophosphamide - Generic mfg.

fludarabine IV - Generic mfg.

WU-NK-101 - Wugen

https://library.ehaweb.org/eha/2023/eha2023-congress/387595/jan.davidson-moncada.a.phase.1.study.of.wu-nk-101.in.patients.with.relapsed.or.html?f=menu%3D16%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2489%2Aot_id%3D27891%2Atrend%3D4016%2Amarker%3D4179

Amanda Cashen; Ashkan Emadi; Edward Abadir; Monzr Al Malki; Peter Tan; Joshua Zeidner; Natasha Edwin; Peter Sayre; Lori Muffly; John Muth; Kenneth Jacobs; Ouiam Bakkacha; Eileen McNulty; Angela Pannunzio; Jan Davidson-Moncada

May 12, 2023